Table 3.

Baseline predictors of side effects at 1 month and 6 months

		1 month		6 months
		r or rp	p	r or rp	p
Age	r	− 0.012	0.916	0.038	0.744
White British	rp	− 0.112	0.334	− 0.097	0.405
Men who have sex with men (MSM)	rp	0.201	0.081	0.114	0.326
Employed	rp	− 0.197	0.088	− 0.184	0.112
AIDS diagnosis	rp	− 0.021	0.859	− 0.104	0.369
Prior antiretroviral therapy (ART)	rp	0.216	0.061	0.114	0.325
Protease-inhibitor-based ART regimen	rp	− 0.722	0.474	− 0.013	0.990
CD4 count (mm3/L)	r	0.151	0.193	0.108	0.353
Viral load (log10 copies/mL)	r	0.103	0.378	0.144	0.216
Duration of HIV diagnosis (years)	r	0.281	0.014	0.296	0.010
BMQ ART-Necessity	r	− 0.177	0.125	− 0.203	0.079
BMQ ART-Concerns	r	0.347	0.002	0.360	0.001
BMQ ART-General Overuse	r	− 0.113	0.383	− 0.103	0.425
BMQ ART-General Harm	r	0.201	0.116	0.178	0.166
BMQ ART-General Benefit	r	− 0.147	0.259	− 0.144	0.267
Perceived Sensitivity to Medicines (PSM)	r	0.262	0.045	0.241	0.066
HADS Depression	r	0.403	0.000	0.450	< 0.001
HADS Anxiety	r	0.454	0.000	0.440	< 0.001

BMQ beliefs about medicines in general, HADS hospital anxiety and depression scale